Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct 100Mo(p,2n) reaction.

Uzunov NM, Melendez-Alafort L, Bello M, Cicoria G, Zagni F, De Nardo L, Selva A, Mou L, Rossi-Alvarez C, Pupillo G, Di Domenico G, Uccelli L, Boschi A, Groppi F, Salvini A, Taibi A, Duatti A, Martini P, Pasquali M, Loriggiola M, Marengo M, Strada L, Manenti S, Rosato A, Esposito J.

Phys Med Biol. 2018 Sep 19;63(18):185021. doi: 10.1088/1361-6560/aadc88.

PMID:
30229740
2.

Cytoplasmic p27Kip1 promotes tumorigenesis via suppression of RhoB activity.

Calvayrac O, Nowosad A, Cabantous S, Lin LP, Figarol S, Jeannot P, Serres M, Callot C, Perchey RT, Creff J, Taranchon-Clermont E, Rouquette I, Favre G, Pradines A, Manenti S, Mazieres J, Lee H, Besson A.

J Pathol. 2018 Sep 11. doi: 10.1002/path.5167. [Epub ahead of print]

PMID:
30206932
3.

A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis.

Adam K, Cartel M, Lambert M, David L, Yuan L, Besson A, Mayeux P, Manenti S, Didier C.

J Cell Sci. 2018 Aug 10;131(15). pii: jcs213116. doi: 10.1242/jcs.213116.

PMID:
29976560
4.

Data Mining Applied to Analysis of Contraceptive Methods Among College Students.

Simões PW, Cesconetto S, Dalló ED, de Souza Pires MM, Comunello E, Borges Tomaz F, Xavier EP, da Rosa Brunel Alves PA, Ceretta LB, Manenti SA.

Stud Health Technol Inform. 2017;245:1287.

PMID:
29295372
5.

Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.

Heydt Q, Larrue C, Saland E, Bertoli S, Sarry JE, Besson A, Manenti S, Joffre C, Mansat-De Mas V.

Oncogene. 2018 Feb 8;37(6):787-797. doi: 10.1038/onc.2017.376. Epub 2017 Oct 23.

6.

Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance.

David L, Manenti S, Récher C, Hoffmann JS, Didier C.

Mol Cell Oncol. 2017 Sep 18;4(5):e1289293. doi: 10.1080/23723556.2017.1289293. eCollection 2017.

7.

Excitation function and yield for the 103Rh(d,2n)103Pd nuclear reaction: Optimization of the production of palladium-103.

Manenti S, Alí Santoro MDC, Cotogno G, Duchemin C, Haddad F, Holzwarth U, Groppi F.

Nucl Med Biol. 2017 Jun;49:30-37. doi: 10.1016/j.nucmedbio.2017.02.005. Epub 2017 Mar 6.

PMID:
28292697
8.

p27Kip1 promotes invadopodia turnover and invasion through the regulation of the PAK1/Cortactin pathway.

Jeannot P, Nowosad A, Perchey RT, Callot C, Bennana E, Katsube T, Mayeux P, Guillonneau F, Manenti S, Besson A.

Elife. 2017 Mar 13;6. pii: e22207. doi: 10.7554/eLife.22207.

9.

Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide.

Lazzerini M, Villanacci V, Pellegrin MC, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Fontana M, Zuin G, Maggiore G, Bramuzzo M, Maschio M, Salemme M, Manenti S, Lorenzi L, Decorti G, Montico M, Ventura A.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1382-1389.e1. doi: 10.1016/j.cgh.2017.02.029. Epub 2017 Mar 7.

PMID:
28286192
10.

CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.

Dozier C, Mazzolini L, Cénac C, Froment C, Burlet-Schiltz O, Besson A, Manenti S.

Oncogene. 2017 Jun 29;36(26):3781-3788. doi: 10.1038/onc.2016.506. Epub 2017 Feb 13.

PMID:
28192398
11.

CHK1 as a therapeutic target to bypass chemoresistance in AML.

David L, Fernandez-Vidal A, Bertoli S, Grgurevic S, Lepage B, Deshaies D, Prade N, Cartel M, Larrue C, Sarry JE, Delabesse E, Cazaux C, Didier C, Récher C, Manenti S, Hoffmann JS.

Sci Signal. 2016 Sep 13;9(445):ra90. doi: 10.1126/scisignal.aac9704.

PMID:
27625304
12.

Phosphorylation of CDC25A on SER283 in late S/G2 by CDK/cyclin complexes accelerates mitotic entry.

Mazzolini L, Broban A, Froment C, Burlet-Schiltz O, Besson A, Manenti S, Dozier C.

Cell Cycle. 2016 Oct 17;15(20):2742-52. doi: 10.1080/15384101.2016.1220455. Epub 2016 Aug 11.

13.

p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.

Duquesnes N, Callot C, Jeannot P, Daburon V, Nakayama KI, Manenti S, Davy A, Besson A.

J Pathol. 2016 Jul;239(3):250-61. doi: 10.1002/path.4721. Epub 2016 May 4.

PMID:
27015986
14.

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.

Bertoli S, Boutzen H, David L, Larrue C, Vergez F, Fernandez-Vidal A, Yuan L, Hospital MA, Tamburini J, Demur C, Delabesse E, Saland E, Sarry JE, Galcera MO, Mansat-De Mas V, Didier C, Dozier C, Récher C, Manenti S.

Oncotarget. 2015 Nov 10;6(35):38061-78. doi: 10.18632/oncotarget.5706.

15.

Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.

Larrue C, Saland E, Boutzen H, Vergez F, David M, Joffre C, Hospital MA, Tamburini J, Delabesse E, Manenti S, Sarry JE, Récher C.

Blood. 2016 Feb 18;127(7):882-92. doi: 10.1182/blood-2015-05-646497. Epub 2015 Aug 18.

16.

Phytotoxicity of ionic, micro- and nano-sized iron in three plant species.

Libralato G, Costa Devoti A, Zanella M, Sabbioni E, Mičetić I, Manodori L, Pigozzo A, Manenti S, Groppi F, Volpi Ghirardini A.

Ecotoxicol Environ Saf. 2016 Jan;123:81-8. doi: 10.1016/j.ecoenv.2015.07.024. Epub 2015 Jul 29.

PMID:
26232851
17.

Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.

Larrue C, Saland E, Vergez F, Serhan N, Delabesse E, Mansat-De Mas V, Hospital MA, Tamburini J, Manenti S, Sarry JE, Récher C.

Mol Cancer Ther. 2015 Oct;14(10):2364-73. doi: 10.1158/1535-7163.MCT-15-0163. Epub 2015 Jul 23.

18.

Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.

Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A.

Inflamm Bowel Dis. 2015 Aug;21(8):1739-49. doi: 10.1097/MIB.0000000000000437.

PMID:
26185909
19.

Fulminant ulcerative colitis in a healthy pregnant woman.

Orabona R, Valcamonico A, Salemme M, Manenti S, Tiberio GA, Frusca T.

World J Gastroenterol. 2015 May 21;21(19):6060-4. doi: 10.3748/wjg.v21.i19.6060.

20.

The metallobiochemistry of ultratrace levels of platinum group elements in the rat.

Sabbioni E, Fortaner S, Manenti S, Groppi F, Bonardi M, Bosisio S, Di Gioacchino M.

Metallomics. 2015 Feb;7(2):267-76. doi: 10.1039/c4mt00240g.

PMID:
25561341
21.

Classification of images acquired with colposcopy using artificial neural networks.

Simões PW, Izumi NB, Casagrande RS, Venson R, Veronezi CD, Moretti GP, da Rocha EL, Cechinel C, Ceretta LB, Comunello E, Martins PJ, Casagrande RA, Snoeyer ML, Manenti SA.

Cancer Inform. 2014 Oct 31;13:119-24. doi: 10.4137/CIN.S17948. eCollection 2014.

22.

Uptake from water, internal distribution and bioaccumulation of selenium in Scenedesmus obliquus, Unio mancus and Rattus norvegicus: part B.

Sabbioni E, Polettini AE, Fortaner S, Farina M, Groppi F, Manenti S, Libralato G.

Bull Environ Contam Toxicol. 2015 Jan;94(1):90-5. doi: 10.1007/s00128-014-1406-3. Epub 2014 Oct 22.

PMID:
25335578
23.

Uptake from water, internal distribution and bioaccumulation of selenium in Scenedesmus obliquus, Unio mancus and Rattus norvegicus: part A.

Polettini AE, Fortaner S, Farina M, Groppi F, Manenti S, Libralato G, Sabbioni E.

Bull Environ Contam Toxicol. 2015 Jan;94(1):84-9. doi: 10.1007/s00128-014-1407-2. Epub 2014 Oct 21.

PMID:
25327388
24.

The excitation functions of (100)Mo(p,x)(99)Mo and (100)Mo(p,2n)(99m)Tc.

Manenti S, Holzwarth U, Loriggiola M, Gini L, Esposito J, Groppi F, Simonelli F.

Appl Radiat Isot. 2014 Dec;94:344-348. doi: 10.1016/j.apradiso.2014.09.010. Epub 2014 Sep 28.

PMID:
25305527
25.

Targeting CHK1 inhibits cell proliferation in FLT3-ITD positive acute myeloid leukemia.

Yuan LL, Green A, David L, Dozier C, Récher C, Didier C, Tamburini J, Manenti S.

Leuk Res. 2014 Nov;38(11):1342-9. doi: 10.1016/j.leukres.2014.08.020. Epub 2014 Sep 16.

PMID:
25281057
26.

The ROS/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs.

Bossis G, Sarry JE, Kifagi C, Ristic M, Saland E, Vergez F, Salem T, Boutzen H, Baik H, Brockly F, Pelegrin M, Kaoma T, Vallar L, Récher C, Manenti S, Piechaczyk M.

Cell Rep. 2014 Jun 26;7(6):1815-23. doi: 10.1016/j.celrep.2014.05.016. Epub 2014 Jun 5.

27.

Physical optimization of production by deuteron irradiation of high specific activity (177g)Lu suitable for radioimmunotherapy.

Manenti S, Bonardi ML, Gini L, Groppi F.

Nucl Med Biol. 2014 May-Jun;41(5):407-9. doi: 10.1016/j.nucmedbio.2014.02.007. Epub 2014 Mar 2.

PMID:
24666720
28.

Incidental 11C-choline PET/CT uptake due to esophageal carcinoma in a patient studied for prostate cancer.

Bertagna F, Bertoli M, Treglia G, Manenti S, Salemme M, Giubbini R.

Clin Nucl Med. 2014 Oct;39(10):e442-4. doi: 10.1097/RLU.0000000000000334.

PMID:
24561683
29.

Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.

Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A.

JAMA. 2013 Nov 27;310(20):2164-73. doi: 10.1001/jama.2013.280777.

PMID:
24281461
30.

Endoscopic and histological pitfalls in the diagnosis of celiac disease: A multicentre study assessing the current practice.

Rostami-Nejad M, Villanacci V, Hogg-Kollars S, Volta U, Manenti S, Reza-Zali M, Caio G, Giovenali P, Barakauskiene A, Kazenaite E, Becheanu G, Diculescu M, Pellegrino S, Magazzù G, Casella G, Di-Bella C, Decarli N, Biancalani M, Bassotti G, Rostami K.

Rev Esp Enferm Dig. 2013 Jul;105(6):326-33.

31.

Using a model of parallel distributed processing associated with data mining in the characterization of sexuality in a university population.

de Azevedo Simões PW, Martins PJ, Casagrandre RA, Madeira K, de Mattos MC, Manenti SA, da Rosa MI, Dal-Pizzol F, Venson R, Coral LN, de Souza GS, Pandini JC, Cassettari Junior JM, Moretti GP, Cesconetto S.

Stud Health Technol Inform. 2013;192:1135.

PMID:
23920909
32.

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.

Thomas D, Powell JA, Vergez F, Segal DH, Nguyen NY, Baker A, Teh TC, Barry EF, Sarry JE, Lee EM, Nero TL, Jabbour AM, Pomilio G, Green BD, Manenti S, Glaser SP, Parker MW, Lopez AF, Ekert PG, Lock RB, Huang DC, Nilsson SK, Récher C, Wei AH, Guthridge MA.

Blood. 2013 Aug 1;122(5):738-48. doi: 10.1182/blood-2012-08-447441. Epub 2013 Jun 17.

33.

Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia.

Yuan LL, Green AS, Bertoli S, Grimal F, Mansat-De Mas V, Dozier C, Tamburini J, Récher C, Didier C, Manenti S.

Leukemia. 2014 Feb;28(2):293-301. doi: 10.1038/leu.2013.168. Epub 2013 Jun 10.

PMID:
23748345
34.

Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells.

Scotland S, Saland E, Skuli N, de Toni F, Boutzen H, Micklow E, Sénégas I, Peyraud R, Peyriga L, Théodoro F, Dumon E, Martineau Y, Danet-Desnoyers G, Bono F, Rocher C, Levade T, Manenti S, Junot C, Portais JC, Alet N, Récher C, Selak MA, Carroll M, Sarry JE.

Leukemia. 2013 Nov;27(11):2129-38. doi: 10.1038/leu.2013.107. Epub 2013 Apr 9.

PMID:
23568147
35.

Extreme variability of Her-2 expression in gastric cancer.

Balzarini P, Manenti S, Gatta LB, Villanacci V.

Dig Liver Dis. 2013 Jul;45(7):616. doi: 10.1016/j.dld.2013.01.024. Epub 2013 Mar 9. No abstract available.

PMID:
23477867
36.

Gastrointestinal and non-gastrointestinal presentation in patients with celiac disease.

Ehsani-Ardakani MJ, Rostami Nejad M, Villanacci V, Volta U, Manenti S, Caio G, Giovenali P, Becheanu G, Diculescu M, Pellegrino S, Magazzù G, Casella G, Di Bella C, Decarli N, Biancalani M, Bassotti G, Hogg-Kollars S, Zali MR, Rostami K.

Arch Iran Med. 2013 Feb;16(2):78-82. doi: 013162/AIM.006.

37.

Doxorubicin promotes transcriptional upregulation of Cdc25B in cancer cells by releasing Sp1 from the promoter.

Dalvai M, Mondesert O, Bugler B, Manenti S, Ducommun B, Dozier C.

Oncogene. 2013 Oct 17;32(42):5123-8. doi: 10.1038/onc.2012.524. Epub 2012 Nov 19.

PMID:
23160377
38.

The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors.

Fialin C, Larrue C, Vergez F, Sarry JE, Bertoli S, Mansat-De Mas V, Demur C, Delabesse E, Payrastre B, Manenti S, Roche S, Récher C.

Leukemia. 2013 Feb;27(2):325-35. doi: 10.1038/leu.2012.240. Epub 2012 Aug 20.

PMID:
22902361
39.

The role of colonic mast cells and myenteric plexitis in patients with diverticular disease.

Bassotti G, Villanacci V, Nascimbeni R, Antonelli E, Cadei M, Manenti S, Lorenzi L, Titi A, Salerni B.

Int J Colorectal Dis. 2013 Feb;28(2):267-72. doi: 10.1007/s00384-012-1554-z. Epub 2012 Aug 5.

PMID:
22864621
40.

[The construction process of managerial profile competencies for nurse coordinators in the hospital field].

Manenti SA, Ciampone MH, Mira VL, Minami LF, Soares JM.

Rev Esc Enferm USP. 2012 Jun;46(3):727-33. Portuguese.

41.

Fukushima fallout at Milano, Italy.

Ioannidou A, Manenti S, Gini L, Groppi F.

J Environ Radioact. 2012 Dec;114:119-25. doi: 10.1016/j.jenvrad.2012.01.006. Epub 2012 Jan 31.

PMID:
22300481
42.

Evaluation of checkpoint kinase targeting therapy in acute myeloid leukemia with complex karyotype.

Didier C, Demur C, Grimal F, Jullien D, Manenti S, Ducommun B.

Cancer Biol Ther. 2012 Mar;13(5):307-13. doi: 10.4161/cbt.19074. Epub 2012 Mar 1.

43.

The cell cycle regulator CDC25A is a target for JAK2V617F oncogene.

Gautier EF, Picard M, Laurent C, Marty C, Villeval JL, Demur C, Delhommeau F, Hexner E, Giraudier S, Bonnevialle N, Ducommun B, Récher C, Laurent G, Manenti S, Mansat-De Mas V.

Blood. 2012 Feb 2;119(5):1190-9. doi: 10.1182/blood-2011-01-327742. Epub 2011 Nov 7.

44.

High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.

Vergez F, Green AS, Tamburini J, Sarry JE, Gaillard B, Cornillet-Lefebvre P, Pannetier M, Neyret A, Chapuis N, Ifrah N, Dreyfus F, Manenti S, Demur C, Delabesse E, Lacombe C, Mayeux P, Bouscary D, Recher C, Bardet V.

Haematologica. 2011 Dec;96(12):1792-8. doi: 10.3324/haematol.2011.047894. Epub 2011 Sep 20.

45.

Epidemiologic and clinical characteristics of pregnant women living with HIV/AIDS in a region of Southern Brazil where the subtype C of HIV-1 infection predominates.

Manenti SA, Galato Júnior J, Silveira Eda S, Oenning RT, Simões PW, Moreira J, Fochesato CM, Brígido LF, Rodrigues R, Romão PR.

Braz J Infect Dis. 2011 Jul-Aug;15(4):349-55.

46.

Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia.

Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Manenti S, Antonelli E, Fanini L, Salerni B.

Dig Dis Sci. 2012 Jan;57(1):65-71. doi: 10.1007/s10620-011-1848-y. Epub 2011 Aug 4.

PMID:
21814802
47.

Tracking of airborne radionuclides from the damaged Fukushima Dai-ichi nuclear reactors by European networks.

Masson O, Baeza A, Bieringer J, Brudecki K, Bucci S, Cappai M, Carvalho FP, Connan O, Cosma C, Dalheimer A, Didier D, Depuydt G, De Geer LE, De Vismes A, Gini L, Groppi F, Gudnason K, Gurriaran R, Hainz D, Halldórsson Ó, Hammond D, Hanley O, Holeý K, Homoki Z, Ioannidou A, Isajenko K, Jankovic M, Katzlberger C, Kettunen M, Kierepko R, Kontro R, Kwakman PJ, Lecomte M, Leon Vintro L, Leppänen AP, Lind B, Lujaniene G, Mc Ginnity P, Mc Mahon C, Malá H, Manenti S, Manolopoulou M, Mattila A, Mauring A, Mietelski JW, Møller B, Nielsen SP, Nikolic J, Overwater RM, Pálsson SE, Papastefanou C, Penev I, Pham MK, Povinec PP, Ramebäck H, Reis MC, Ringer W, Rodriguez A, Rulík P, Saey PR, Samsonov V, Schlosser C, Sgorbati G, Silobritiene BV, Söderström C, Sogni R, Solier L, Sonck M, Steinhauser G, Steinkopff T, Steinmann P, Stoulos S, Sýkora I, Todorovic D, Tooloutalaie N, Tositti L, Tschiersch J, Ugron A, Vagena E, Vargas A, Wershofen H, Zhukova O.

Environ Sci Technol. 2011 Sep 15;45(18):7670-7. doi: 10.1021/es2017158. Epub 2011 Aug 23.

PMID:
21809844
48.

Non-IBD colitides: clinically useful histopathological clues.

Villanacci V, Manenti S, Antonelli E, Chiudinelli M, Giuliano V, Bassotti G.

Rev Esp Enferm Dig. 2011 Jul;103(7):366-72. Review. English, Spanish.

49.

Gastrointestinal Foxp3 expression in normal, inflammatory and neoplastic conditions.

Villanacci V, Not T, Nascimbeni R, Ferrara F, Tommasini A, Manenti S, Antonelli E, Bassotti G.

Pathology. 2011 Aug;43(5):465-71. doi: 10.1097/PAT.0b013e3283485e37.

PMID:
21670722
50.

Colonic mast cells in controls and slow transit constipation patients.

Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Manenti S, Sabatino G, Maurer CA, Cathomas G, Salerni B.

Aliment Pharmacol Ther. 2011 Jul;34(1):92-9. doi: 10.1111/j.1365-2036.2011.04684.x. Epub 2011 May 3.

Supplemental Content

Loading ...
Support Center